Shopping Cart
Remove All
Your shopping cart is currently empty
JNK-IN-24 is a JNK inhibitor and an anti-metastatic cancer agent. It reduces the expression of JNK and MMP1 in cancer tissues induced by Scrib knockdown. JNK-IN-24 aids in the recovery of the ScribRNAi tumor disc phenotype and is applicable for studying various epithelial-derived cancers.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | JNK-IN-24 is a JNK inhibitor and an anti-metastatic cancer agent. It reduces the expression of JNK and MMP1 in cancer tissues induced by Scrib knockdown. JNK-IN-24 aids in the recovery of the ScribRNAi tumor disc phenotype and is applicable for studying various epithelial-derived cancers. |
| In vivo | JNK-IN-24 (Compound 5 f), incorporated into corn agar-based food medium at concentrations ranging from 15 to 1000 μM, does not exhibit lethality during the development of wild-type pupae. Within the 250-1000 μM range, JNK-IN-24 can prevent early pupal death, allowing complete differentiation into pre-emergent adults and aiding recovery of Scrib Scrib RNAi tumor wing disc phenotypes. |
| Molecular Weight | 360.79 |
| Formula | C19H17ClO5 |
| Cas No. | 2226808-28-0 |
| Smiles | O=C(OCC)C1=C(OC=2C=C(O)C=C(O)C2C1C3=CC=C(Cl)C=C3)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.